Speciality: Oncology
Description:
Welcome to our special feature on relapsed B-cell Acute Lymphoblastic Leukemia (B-cell ALL) in adults. Join leading experts Dr. Riyaz Ahmad, Dr. Nitin Gupta, and Dr. Eesha Kaul as they explore the latest breakthroughs in treating this aggressive form of leukemia. With years of experience in hematology and oncology, they bring valuable insights into how modern medicine is reshaping the outlook for adult patients.
In this video, our experts discuss the challenges of relapsed B-cell ALL and how innovative treatments like CAR T-cell therapy, blinatumomab, and inotuzumab ozogamicin are offering new hope. They highlight the importance of precision medicine, the evolving role of stem cell transplantation, and the need for holistic care in improving outcomes and quality of life for patients.
Thank you for watching. We hope this video offers clarity and encouragement to patients, families, and healthcare professionals. Don’t forget to like, share, and follow our channel for more updates on cutting-edge treatments and expert perspectives in cancer care.
See More Webinars @ Hidoc Webinars
1.
Children living near oil and gas wells face higher risk of rare leukemia, studies show
2.
Lung nodules seen in a high percentage of non-smokers
3.
AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence
4.
Colon cancer and exercise: Can physical activity reprogram genes?
5.
Black women are more likely to die of breast cancer. Close the gap by looking into mammogram studies.
1.
Understanding QSOFA: A Vital Tool for Recognizing Sepsis
2.
Can Wearables and AI Become a Gamechanger for Histiocytic Cancer Detection?
3.
Understanding Pancreatic Cancer: Symptoms, Causes and Risk Factors
4.
Screening Strategies in Oncology: A Subspecialty Guide to Early Detection and Better Outcomes
5.
CA-125 Test: Why It's Important for Women's Health and Early Detection of Ovarian Cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
5.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation